18.04.2011 • NewsContinental

Continental to Buy Indian Modi Rubber's Tire Unit

German tire maker Continental has signed an agreement to buy the tire unit of India's Modi Rubber, Continental said on Monday.

It did not disclose financial details, and said the completion of the deal to acquire Modi Tyres "depends on the fulfillment of several conditions."

Shares in Modi Rubber shot up 10%, its daily limit, to 75.35 rupees on the Bombay Stock Exchange.

Continental, the world's fourth largest tire maker with reported sales of 26 billion euros ($37.5 billion) in 2010, said Modi Tyres would become a fully owned subsidiary and would focus on local production and distribution of radial truck and bus tires as well as radial car tires.

"This development underlines Continental's commitment to the Indian market and is part of the company's strategy to invest in growing markets in Asia for its core businesses," it said in a statement.

Auto sales in India grew a record 30% in 2010/11 to 1.98 million units, driven by a burgeoning middle class in Asia's third-largest economy, easier access to loans and a wider choice of models.

But higher input costs and interest rates are seen crimping demand for cars and sales growth is expected to more than halve in 2011/12 to 12-15%.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.